Contact
Please use this form to send email to PR contact of this press release:
Acura Pharmaceuticals Receives Second U.S. Patent for Novel Limitx(TM) Abuse Deterrent Technology
TO:
Please use this form to send email to PR contact of this press release:
Acura Pharmaceuticals Receives Second U.S. Patent for Novel Limitx(TM) Abuse Deterrent Technology
TO: